1. Court JA and Perry EK (1991): Dementia — The neurochemical basis of putative transmitter orientated therapy. Pharmac Ther 52: 423–443.
2. Harman D, Eddy DE and Noffsinger J (1976): Free radical theory of aging: inhibition of amyloidosis in mice by antioxidants; possible mechanisms. J Am Geriatr Soc 24 (5): 203–210.
3. Lukianova LD, Atabaeva RE and Shepeleva SG (1993): Study of bioenergetic mechanisms of antihypoxic effect of succinate containing derivative of 3hydroxypyridine (Mexidol). Bull Exper Biol Med (Moscow) 3: 259–260.
4. Miller SW, Mahoney JM and Jann MW (1992): Therapeutic frontiers in Alzheimer’s disease. Pharmacotherapy 12 (3): 217–231.
5. Nitsch R, Puttas A, Bluszain JK, Slak BE, Growdon JH, and Wurtman RJ (1991): Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer’s disease. In: Aging and Alzheimer’s Disease - Annals of New York Academy of Sciences. Growdon JH, Corkin S, Ritter-Walker J and Wurtman RI, eds. New York: Elsevier 640: 110–113.